cis-Anethole is the Z isomer of anethole, a minor phenylpropanoid found in anise-, fennel-, and star-anise-type materials already represented in the AromaForge archive. The strongest source-grounded evidence is identity, trace occurrence, and chemistry: public sources consistently place cis-anethole at much lower levels than trans-anethole and describe it as a less desirable isomer that can form during light- or acid-driven isomerization of trans-anethole. Direct constituent-specific wellness evidence is weak, so this record should stay focused on composition, isomerization, and cautious safety framing rather than medical claims.
Aroma and practical use
- Use the recorded anise-like, sweet, spicy, less desirable than trans-anethole descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2010 Molecules study on anethole transformation reported that cis-anethole forms when trans-anethole is exposed to UV-Vis irradiation or acidic zeolite conditions, with isomerization competing against dimer formation.
A 2010 Molecules study on anethole transformation reported that cis-anethole forms when trans-anethole is exposed to UV-Vis irradiation or acidic zeolite conditions, with isomerization competing against dimer formation.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
The EMA bitter-fennel monograph sets cis-anethole at 0.5% max in the pharmacopoeial profile for bitter fennel fruit oil, reinforcing its status as a constrained minor constituent rather than a core marker.
The EMA bitter-fennel monograph sets cis-anethole at 0.5% max in the pharmacopoeial profile for bitter fennel fruit oil, reinforcing its status as a constrained minor constituent rather than a core marker.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
Multiple secondary sources reviewed in this pass describe cis-anethole as a less desirable and more toxic isomer than trans-anethole, but a standalone modern toxicology monograph focused on isolated cis-anethole was not verified here.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
EMA composition limits for anise and bitter fennel keep cis-anethole at low or trace levels, which is the clearest directly verified safety-relevant archive signal in this pass.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
photoisomerization_and_acid_catalyzed_isomerization
A directly readable chemistry paper reports that exposure of trans-anethole to UV irradiation or acid sites generates cis-anethole, supporting a clear isomerization mechanism rather than a biological one.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- A dedicated modern toxicology source focused specifically on isolated cis-anethole was not verified in this pass.
- Most biological or therapeutic literature centers on trans-anethole or whole anise-family extracts rather than cis-anethole alone.
- Public constituent-specific dermal or inhalation limits for isolated cis-anethole were not verified here.
- A c6 verification search (2026-07-13) confirmed cis-anethole is reported 15-38x more acutely toxic to animals than trans-anethole (secondary sources, no direct citation with numeric dermal limit located) and is kept to trace/regulated levels by EMA composition limits, but no RIFM/IFRA dermal-limit percentage specific to isolated cis-anethole was found; the prior unsourced 0.7% dermal_limit_pct (likely carried over from trans-anethole IFRA data) was corrected to null.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.